4 models fit Plexus Corp. Common Stock and they disagree: 1 of 4 land within 15% of the average.
Two or more of our models back this value.
Large premium(i)Bronze47
Valued as a mature, profitable company: Discounted cash flow, P/E comparison, EV/EBITDA comparison, Graham number, and Dividend discount.
ACCE opinionPlexus Corp. Common Stock (PLXS)
Fair value (4 models)
$145
ACCE price target
$248
Rating
Overvalued
Horizon
12 months
Fair value published on 24 Oct 2026, 16:06 CEST; previously $167 since 12 Oct 2026, 00:00 CEST.
ACCE price target published on 10 Oct 2026, 00:00 CEST.
Rating published on 24 Oct 2026, 16:06 CEST.
Price used: $217 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, P/E comparison, EV/EBITDA comparison, and Graham number.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
49.2% above
-33.0% to fair value
ACCE score
51
out of 100
Analysts
100% buy
5 covering
P/E
32.1x
forward 21.4x
1-year return
+44.8%
Dividend yield
0.00%
Plexus Corp. Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Plexus is an electronics manufacturing services company that builds printed circuit board assemblies and complete systems for customers in medical, industrial, aerospace and defense, and secure markets, with a strong position in regulated end-markets where qualification cycles are long and switching is costly. Its moat rests on those multi-year qualifications and on engineering depth in complex, low-volume, high-mix production, which tends to keep customers in place for many product generations. Revenue growth of 28.1% is the headline catalyst, and the forward P/E of 24.2 against a trailing 34.0 implies the market expects earnings to catch up with sales as the mix shifts toward higher-value programs. The thin 10.0% gross margin and 4.7% operating margin mean execution and pricing discipline matter more here than in most tech names, and a 12.6% ROE shows the business is not yet converting growth into exceptional returns. The thesis is worth a deeper look if margin expansion is visible in the next reported quarters; if it is not, the growth is buying less than it appears.
⚠ Investor warnings · 4 flagsAI-assisted·How I use AI
high
Earnings declining despite revenue growth
Revenue grew 28.1% year over year, yet earnings fell 3.7%. Net margin sits at 4.0%, so the top-line gains are not reaching the bottom line.
moderate
Valuation stretched against model fair value
The stock trades 49.2% above the model fair value of $145.41, and the P/E of 34.0 is well above the forward P/E of 24.2, which implies expected earnings growth must come through.
moderate
ACCE score fell sharply
The composite score dropped 10 points over 90 days, from 65 to 55, with the valuation component at 45 and the growth component at 52.
moderate
Insider selling without buying
Insiders sold $5.87M across the last 10 disclosed transactions and bought nothing, while insiders hold only 1.4% of shares.
AI research notes
AI-assisted·How I use AIWritten Oct 18, 2026 · figures from 2026-10-16 · prices to Oct 23, 2026
Why it could do well
Revenue grew 28.1% over the last year, far faster than its 3.5% average annual pace over five years.
Latest quarterly earnings beat expectations by 24.4%, and the company has a low debt to equity ratio of 0.12.
Why it could disappoint
At $216.98, the shares trade 49.2% above the model fair value of $145.41, which is the consensus of four valuation models.
A net margin of 4.0% and return on invested capital of 8.7% leave little profit from each dollar of sales.
The 2.5% free cash flow yield and 34.0x trailing P/E look expensive against a sector median forward P/E of 28.8x.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Next results
Oct 28, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where PLXS's valuation models land
Price
$216.98
Model fair value
$145
Model range
$76.78 to $263
Fair value $145
Price $217
The price sits inside the model range.
Model
Fair value
Upside
Discounted cash flow
Dividend discount
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores